FBCD >>LOI GOLD MINE NEWZZZ//announces another Executed LOI with Dutch Gold Resources, Inc.
By FBC Holdings
Published: Tuesday, May. 7, 2013 - 9:08 am
NEW YORK, May 7, 2013 -- /PRNewswire/ -- (OTCQB: FBCD) FBC Holding, Inc. would like to update its shareholders on recent events.
FBC Holding announced today that the Company has executed a Letter of Intent with Dutch Gold Resources (OTC Pink: DGRI). Under terms of the agreement the parties will investigate several opportunities which DGRI has identified and developed preliminary business plans. These opportunities are all related to gold mining or gold mining services in Nicaragua. Frank Russo, CEO of FBCD said, "These opportunities appear to be very attractive and DGRI and their staff have completed a great deal of in-depth investigation of the opportunities and establishing the required relationships. We excited to be proceeding to the next step with this as well as our other opportunities."
"We have discovered multiple opportunities to develop in Nicaragua, some with short-term cash flow potential and some with long-range potentially large deposits. Given the extent of the multiple opportunities, we are pleased to bring in other financing sources and are pleased to announce this relationship with FBC Holding, Inc.," said Daniel Hollis, CEO of Dutch Gold.
Disclaimer and Release of Liability
The Company is advising readers that non-affiliate shareholders of the company, and the Company may, from time to time, engage the services of unaffiliated firms to provide investor relations and advertising services. These third party shareholders may own the Company's shares and plan to liquidate, which may negatively affect the stock price. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. The Company does not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by the Company or an offer or solicitation to buy or sell any security. Neither the Company nor any of its members, officers, directors, debt-holders, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, registered investment advisors, analyst or underwriters. Readers should always consult with a licensed securities professional before purchasing or selling any securities of any company including our own. It is possible that a reader's entire investment may be lost or impaired due to the speculative nature of the investment.
Some of the content in this release may contain forward - looking information within the meaning of Section 27 A of the Securities Act of 1 9 9 3 and Section 21 E of the Securities Exchange Act of 1 9 3 4 including statements regarding expected continual growth of the Company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward - looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company's filings with the Securities and Exchange Commission. However, a company's past performance does not guarantee future results. Remember, never invest in any security of a company unless you can afford to lost your entire investment. Also investing in micro-cap securities is highly speculative and carries and extremely high degree of risk
We encourage readers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov and/or then FINRA at:www.finra.org. In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/Investors/index.
Contact FBC Holdings info@fbcholding.com
SOURCE FBC Holdings
Read more here: http://www.sacbee.com/2013/05/07/5400440/fbc-...rylink=cpy
Posted On: 05/07/2013 9:22:42 AM
Post# of 25193
(0)
(0)
Top 10 Most Recent Blog Posts
Tilray Brands, Inc. (TLRY): A Global Cannabis Leader
Category: Stocks Total Views: 113
By : Kelly Martin Updated: 07-29-2024
Overview of Tilray Brands, Inc.
Tilray Brands, Inc. (NASDAQ: TLRY) is a pioneering company in the field of medical and recreational cannabis production and research. Headquartered in Canada, Tilray has positioned itself as a global leader with a commitment to providing safe, consistent, and reliable therapy to patients and consumers worldwide. The company operates in multiple regions, including Canada, the United States, Europe, Australia, and Latin America, serving a diverse clientele rangin... Continue Reading
Understanding the Demand Generation Process for Business Growth
Category: Business Total Views: 130
By : Ryan Hughes Updated: 07-29-2024
Introduction to Demand Generation
In the fast-paced world of digital marketing and advertising, understanding the demand generation process is crucial for business growth. Demand generation is a comprehensive strategy aimed at creating awareness and interest in a company's products or services, ultimately driving customer engagement and revenue. For advertisers, especially in the realm of connected TV advertising, mastering demand generation can significantly enhance performance marketing... Continue Reading
Philips Unveils New AI Cardiovascular Ultrasound Platform
Category: Stocks Total Views: 127
By : Henry Turner Updated: 07-29-2024
Philips Reports Strong Order Intake Growth in Q2 2024
With a 9% rise over past periods, Philips's order intake in Q2 2024 rose significantly. Mostly, the North American market drove this expansion. With group sales of EUR 4.5 billion, the company said that comparable sales had risen by 2%. Operations brought in EUR 816 million, of which EUR 538 million came from insurance earnings. The changed EBITA margin climbed to 11.1% of sales. Apart from a free cash outflow of EUR 64 million, Philip... Continue Reading
High-Purity Canola Protein: Burcon’s New Achievement
Category: Stocks Total Views: 159
By : Dominic Sanders Updated: 07-29-2024
Burcon NutraScience Achieves Milestone in Canola Protein Production
Leader in plant-based protein technologies, Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) has effectively finished its first end-to-end validation trial for manufacturing high-purity canola protein isolate. For Burcon's goal of releasing creative, plant-based protein solutions onto the market, this success represents a major forward step.
Commercialization of Canola Protein Technology
Burcon's commerc... Continue Reading
Cosa's Orbit Project Gains Untapped Exploration Areas
Category: Stocks Total Views: 162
By : Caleb Price Updated: 07-29-2024
Acquisition of Mineral Claims in Athabasca Basin
Skyharbour Resources LTD. has signed an asset purchase agreement with Cosa Resources Corp. Signed July 26, 2024, the agreement calls for acquiring two mineral claims in the Athabasca Basin, Saskatchewan. With 12,718 hectares, these claims will double the footprint of the Orbit uranium project. With this purchase, Cosa will be able to increase its eight kilometer control of untested strike length. The claims follow trend with uranium mineralizat... Continue Reading
Hyperfast Title Joins reAlpha's AI Homebuying Platform
Category: Stocks Total Views: 193
By : Riley Hayes Updated: 07-29-2024
reAlpha Acquires 85% Stake in Hyperfast Title, LLC
85% of Hyperfast Title, LLC. has been acquired by reAlpha Tech Corp. Hyperfast calls Florida, Virginia, and Tennessee home. This purchase expands the portfolio of reAlpha with title and settlement services. Re Alpha is renowned for creating real estate artificial intelligence technologies. The purchase from Madison Settlement Services fits the expansion plan of reAlpha. This action enhances the homebuying market offerings from reAlpha. The in... Continue Reading
Long-term Projections for AI Technologies Development
Category: Business Total Views: 159
By : Hannah Lewis Updated: 07-29-2024
The Rise of Generative AI: Transforming Industries and Investment Strategies
By allowing the creation of fresh content—text and images as well as music and design—generative artificial intelligence is changing sectors. Companies use this technology to improve operations and boost inventiveness. Generative artificial intelligence creates tailored marketing materials in advertising, so boosting interaction. In the medical field, it helps with new medical imaging creation and drug di... Continue Reading
New Alzheimer's Treatment: Anavex's Blarcamesine Success
Category: Stocks Total Views: 238
By : Addison Perry Updated: 07-29-2024
Anavex Life Sciences Reports Promising Results for Alzheimer's Treatment
From its Phase IIb/III study on blarcamesine (ANAVEX®2-73), a medication for early Alzheimer's disease (AD), Anavex Life Sciences Corp. (Nasdaq: AVXL) has reported encouraging findings. Leading neurology specialist Dr. Marwan Noel Sabbagh delivered the data at the 2024 Alzheimer's Association International Conference (AAIC). Taken once daily, blarcamesine has shown great promise in halting the advance of ... Continue Reading
Windtree's Latest Advances: Istaroxime Clinical Trials
Category: Stocks Total Views: 287
By : Lucas Young Updated: 07-28-2024
Windtree Therapeutics Updates Istaroxime Clinical Development and Trial Data
Providing a thorough update on the clinical and business development of istaroxime, Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company committed to developing creative therapies for critical diseases, has This first-in-class treatment seeks to raise blood pressure, preserve or increase renal function, and strengthen systolic contraction and diastolic relaxation of the heart. In three Phase 2 trials... Continue Reading
SEC Charges Citron Capital in Multi-Year Fraud Scheme
Category: Investing Total Views: 267
By : Evelyn Baker Updated: 07-28-2024
SEC Charges Andrew Left and Citron Capital in $20 Million Fraud Scheme
Andrew Left and his company, Citron Capital LLC, have been charged with a $20 million fraud by the Securities and Exchange Commission (SEC). They are activists short sellers. The SEC complaint claims Left recommended stock positions using his Citron Research website and social media platform. He said these positions complemented Citron Capital's and his own investments. Left's recommendations, according to the SEC,... Continue Reading